These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 36245371)
1. The tumor microenvironment and prognostic role of autophagy- and immune-related genes in bladder cancer. Gao Z; Chen C; Gu P; Chen J; Liu X; Shen J Cancer Biomark; 2022; 35(3):293-303. PubMed ID: 36245371 [TBL] [Abstract][Full Text] [Related]
2. Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer. Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B Hum Genomics; 2021 Dec; 15(1):73. PubMed ID: 34930465 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis Identified ETV7 as a Potential Prognostic Biomarker in Bladder Cancer. Li H; Zhang Y; Zheng S Biomed Res Int; 2021; 2021():8530186. PubMed ID: 34926692 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value and underlying mechanism of autophagy-related genes in bladder cancer. Peng S; Ma S; Yang F; Xu C; Li H; Lu S; Zhang J; Jiao J; Han D; Shi C; Zhang R; Yang AG; Zhang K; Wen W; Qin W Sci Rep; 2022 Feb; 12(1):2219. PubMed ID: 35140317 [TBL] [Abstract][Full Text] [Related]
5. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer. Wang Z; Tu L; Chen M; Tong S BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144 [TBL] [Abstract][Full Text] [Related]
6. A novel focal adhesion-related risk model predicts prognosis of bladder cancer -- a bioinformatic study based on TCGA and GEO database. Hu J; Wang L; Li L; Wang Y; Bi J BMC Cancer; 2022 Nov; 22(1):1158. PubMed ID: 36357874 [TBL] [Abstract][Full Text] [Related]
7. A Robust Hypoxia Risk Score Predicts the Clinical Outcomes and Tumor Microenvironment Immune Characters in Bladder Cancer. Liu Z; Tang Q; Qi T; Othmane B; Yang Z; Chen J; Hu J; Zu X Front Immunol; 2021; 12():725223. PubMed ID: 34484235 [TBL] [Abstract][Full Text] [Related]
8. The role of radiotherapy-related autophagy genes in the prognosis and immune infiltration in lung adenocarcinoma. Gao J; Lu F; Yan J; Wang R; Xia Y; Wang L; Li L; Chang L; Li W Front Immunol; 2022; 13():992626. PubMed ID: 36311724 [TBL] [Abstract][Full Text] [Related]
9. Deciphering the immunological and prognostic features of bladder cancer through platinum-resistance-related genes analysis and identifying potential therapeutic target P4HB. Xiong S; Li S; Zeng J; Nie J; Liu T; Liu X; Chen L; Fu B; Deng J; Xu S Front Immunol; 2023; 14():1253586. PubMed ID: 37790935 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation. Wang X; Bai Y; Zhang F; Li D; Chen K; Wu R; Tang Y; Wei X; Han P Front Immunol; 2023; 14():955949. PubMed ID: 37006317 [TBL] [Abstract][Full Text] [Related]
11. Identification of Immune-Related Subtypes and Construction of a Novel Prognostic Model for Bladder Urothelial Cancer. Zhang J; Huang C; Yang R; Wang X; Fang B; Mi J; Yuan H; Mo Z; Sun Y Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421685 [TBL] [Abstract][Full Text] [Related]
12. Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancer. Qu G; Liu Z; Yang G; Xu Y; Xiang M; Tang C Aging (Albany NY); 2021 Apr; 13(8):12099-12112. PubMed ID: 33888644 [TBL] [Abstract][Full Text] [Related]
13. Robust pyroptosis risk score guides the treatment options and predicts the prognosis of bladder carcinoma. Deng D; Liu F; Liu Z; Wu Z; He Y; Zhang C; Zu X; Ou Z; Wang Y Front Immunol; 2022; 13():965469. PubMed ID: 36090967 [TBL] [Abstract][Full Text] [Related]
14. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer. Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606 [TBL] [Abstract][Full Text] [Related]
15. Establishment of a risk score model for bladder urothelial carcinoma based on energy metabolism-related genes and their relationships with immune infiltration. Huang C; Li Y; Ling Q; Wei C; Fang B; Mao X; Yang R; Zhang L; Huang S; Cheng J; Liao N; Wang F; Mo L; Mo Z; Li L FEBS Open Bio; 2023 Apr; 13(4):736-750. PubMed ID: 36814419 [TBL] [Abstract][Full Text] [Related]
16. Characterization of an Autophagy-Immune Related Genes Score Signature and Prognostic Model and its Correlation with Immune Response for Bladder Cancer. Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M Cancer Manag Res; 2022; 14():67-88. PubMed ID: 35023971 [TBL] [Abstract][Full Text] [Related]
17. Expression and Prognostic Values of the Roof Plate-Specific Spondin Family in Bladder Cancer. Gao L; Meng J; Zhang M; Fan S; Gao S; Wang X; Liang C DNA Cell Biol; 2020 Jun; 39(6):1072-1089. PubMed ID: 32352838 [TBL] [Abstract][Full Text] [Related]
18. Uncovering the potential functions of lymph node metastasis-associated aberrant methylation differentially expressed genes and their association with the immune infiltration and prognosis in bladder urothelial carcinoma. Gao W; Zhang J; Tian T; Fu Z; Bai L; Yang Y; Wu Q; Wang W; Guo Y PeerJ; 2023; 11():e15284. PubMed ID: 37123010 [TBL] [Abstract][Full Text] [Related]
19. Bioinformatics Analysis to Screen the Key Prognostic Genes in Tumor Microenvironment of Bladder Cancer. Zhang Z; Chen D; Li Z; Liu Z; Yan L; Xu Z Biomed Res Int; 2020; 2020():6034670. PubMed ID: 32149116 [TBL] [Abstract][Full Text] [Related]
20. A co-expression network for differentially expressed genes in bladder cancer and a risk score model for predicting survival. Chen Z; Liu G; Hossain A; Danilova IG; Bolkov MA; Liu G; Tuzankina IA; Tan W Hereditas; 2019; 156():24. PubMed ID: 31333338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]